Bringing immune-checkpoint inhibitors earlier in the management of non-small cell lung cancer

被引：0
|
作者：
Borgeaud, Maxime [1 ]
Friedlaender, Alex [1 ,2 ]
Addeo, Alfredo [1 ,3 ]
机构：
[1] Univ Hosp Geneva HUG, Dept Oncol, Geneva, Switzerland
[2] Clin Gen Beaulieu, Dept Oncol, Geneva, Switzerland
[3] Univ Hosp Geneva HUG, Dept Oncol, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2023年 / 12卷 / 11期
关键词：
Neoadjuvant immune checkpoint inhibitor; non-small-cell lung cancer (NSCLC); perioperative immune checkpoint inhibitors; ADJUVANT CHEMOTHERAPY; PHASE-III; CISPLATIN; SURGERY;
D O I：
10.21037/tlcr-23-466
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2353 / 2358
页数：6
相关论文
共 50 条
  • [1] Endocrinopathies induced by immune-checkpoint inhibitors in advanced non-small cell lung cancer
    Rossi, Emanuela
    Sgambato, Assunta
    De Chiara, Giovanni
    Casaluce, Francesca
    Losanno, Tania
    Sacco, Paola Claudia
    Santabarbara, Giuseppe
    Gridelli, Cesare
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (03) : 419 - 428
  • [2] Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology
    Manglaviti, Sara
    Brambilla, Marta
    Signorelli, Diego
    Ferrara, Roberto
    Lo Russo, Giuseppe
    Proto, Claudia
    Galli, Giulia
    De Toma, Alessandro
    Occhipinti, Mario
    Viscardi, Giuseppe
    Beninato, Teresa
    Zattarin, Emma
    Bini, Marta
    Lobefaro, Riccardo
    Massa, Giacomo
    Bottiglieri, Achille
    Apollonio, Giulia
    Sottotetti, Elisa
    Di Mauro, Rosa Maria
    Trevisan, Benedetta
    Ganzinelli, Monica
    Fabbri, Alessandra
    de Braud, Filippo G. M.
    Garassino, Marina Chiara
    Prelaj, Arsela
    CLINICAL LUNG CANCER, 2022, 23 (01) : E17 - E28
  • [3] Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selection
    Banna, Giuseppe Luigi
    Passiglia, Francesco
    Colonese, Francesca
    Canova, Stefania
    Menis, Jessica
    Addeo, Alfredo
    Russo, Antonio
    Cortinovis, Diego Luigi
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 129 : 27 - 39
  • [4] Immune checkpoint inhibitors in non-small cell lung cancer
    Eberhardt, Wilfried Ernst Erich
    ONKOLOGE, 2017, 23 (10): : 838 - 844
  • [5] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Herzberg, Benjamin
    Campo, Meghan J.
    Gainor, Justin F.
    ONCOLOGIST, 2017, 22 (01): : 81 - 88
  • [6] Efficacy of immune-checkpoint inhibitors in advanced non-small cell lung cancer patients with different metastases
    Qiao, Meng
    Zhou, Fei
    Hou, Likun
    Li, Xuefei
    Zhao, Chao
    Jiang, Tao
    Gao, Guanghui
    Su, Chunxia
    Wu, Chunyan
    Ren, Shengxiang
    Zhou, Caicun
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (01)
  • [7] Impact of corticosteroids and antibiotics on efficacy of immune-checkpoint inhibitors in advanced non-small cell lung cancer
    Mosquera Martinez, J.
    Riuvadets, M.
    Garcia-Campelo, M-R.
    Serra Lopez, J.
    Anguera Palacios, G.
    Gallardo Melo, P.
    Sullivan, I.
    Barba Joaquin, A.
    Majem Tarruella, M.
    Reboredo Rendo, C.
    Cordeiro Gonzalez, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [8] Immune-Checkpoint Inhibitors: Biomarkers to Predict Response to Immunotherapy in Non-small Cell Lung Cancer Patients
    Tostes, Senhorita Katiane
    Sorroche, Bruna Pereira
    Rodrigues, Nathalia de Carvalho
    Dias, Tauana Christina
    Lima, Joyce Alessandra
    Ferreira da Silva, Flavio Augusto
    Martins de Marchi, Pedro Rafael
    Pinheiro, Celine Marques
    Leal, Leticia Ferro
    Rebolho Batista Arantes, Lidia Maria
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S26 - S26
  • [9] Neoadjuvant Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    Xue, Chongxiang
    Dong, Huijing
    Chen, Ying
    Lu, Xingyu
    Zheng, Shuyue
    Cui, Huijuan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (06): : 779 - 788
  • [10] Highlights on immune checkpoint inhibitors in non-small cell lung cancer
    Shen, Meng
    Ren, Xiubao
    TUMOR BIOLOGY, 2017, 39 (03)
12345